Cited by 71Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingAlzheimer's disease research and treatments

C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain

Open access
Wang, Hualong, Chen, Guiqin, Ahn, Eun Hee, Xia, Yiyuan, Kang, Seong Su, Liu, Xia, Liu, Chang, Han, Ming-Hu +2 more·2023·npj Parkinson's Disease

Abstract

Parkinson’s disease (PD) is the most common neurodegenerative motor disorder, and its pathologic hallmarks include extensive dopaminergic neuronal degeneration in the Substantia nigra associated with Lewy bodies, predominantly consisting of phosphorylated and truncated α-Synuclein (α-Syn). Asparagine endopeptidase (AEP) cleaves human α-Syn at N103 residue and promotes its aggregation, contributing to PD pathogenesis. However, how AEP mediates Lewy body pathologies during aging and elicits PD onset remains incompletely understood. Knockout of AEP or C/EBPβ from α-SNCA mice, and their chronic rotenone exposure models were used, and the mechanism of α-Syn from the gut that spread to the brain was observed. Here we report that C/EBPβ/AEP pathway, aggravated by oxidative stress, is age-dependently activated and cleaves α-Syn N103 and regulates Lewy body-like pathologies spreading from the gut into the brain in human α-SNCA transgenic mice. Deletion of C/EBPβ or AEP substantially diminished the oxidative stress, neuro-inflammation, and PD pathologies, attenuating motor dysfunctions in aged α-SNCA mice. Noticeably, PD pathologies initiate in the gut and progressively spread into the brain. Chronic gastric exposure to a low dose of rotenone initiates Lewy body-like pathologies in the gut that propagate into the brain in a C/EBPβ/AEP-dependent manner. Hence, our studies demonstrate that C/EBPβ/AEP pathway is critical for mediating Lewy body pathology progression in PD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41531-022-00430-8

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C/EBPβ/AEP signaling is age-dependently activated in human α-synuclein transgenic mice and PD patients and is responsible for mediating microglial activation and PD pathologies.

    “A recent study found that the C/EBPβ/AEP signaling is age-dependently activated in human α-synuclein transgenic mice and PD patients, which is responsible for mediating microglial activation and PD pathologies.334”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 75 · Cited by 71

Research works printed but not linked: 1

  1. [73]Eun Hee Ahn, S. S. K. et al. Initiation of Parkinson’s disease from gut to brain by delta-secretase. Cell Res.30, 70–87 (2020). PMC6951265 31649329

Authors
Wang, H., Chen, G., Ahn, E. H., Xia, Y., Kang, S. S., Liu, X., Liu, C., Han, M.-H., Chen, S., & Ye, K.
Affiliations
  • Hebei Medical University (CN)
  • Emory University (US)
  • Hallym University (KR)
  • Chinese Academy of Sciences (CN)
  • Shanghai Jiao Tong University (CN)
Corresponding author
  • Chen, Shengdi
  • Ye, Keqiang
Venue
npj Parkinson's Disease
Published
2023-01-06
Volume
9
Issue
1
Pages
1-1
ISSN
2373-8057 (ISSN-L)
OpenAlex
W4313649134
Cited by
71
References
75
Citations by year
2026: 9 · 2025: 32 · 2024: 28 · 2023: 2
FWCI
12.00
Type
journal article
Language
en
Open access
Locations
  • npj Parkinson s Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Emory University (P30NS055077)
  • National Natural Science Foundation of China (2017-01-07-00-01-E00046, 2018SHZDZX05, 201701, 81901292)
  • Shanghai Municipal Education Commission (2017-01-07-00-01-E00046, 2018SHZDZX05)
  • National Institutes of Health (UL1TR002378)
  • School of Medicine, Emory University (UL1-TR002378, P30NS055077)
  • National Institute of Neurological Disorders and Stroke (P30NS055077)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
Parkinson's disease, C/EBPβ, asparaginyl endopeptidase, alpha-synuclein, Lewy bodies, gut-brain axis, rotenone, oxidative stress, neuroinflammation, aging, motor impairment, protein aggregation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review